Understanding genetic mechanisms of Fragile X disorders
Administrative Core
This study is looking into how certain changes in a gene called FMR1 might cause conditions like Fragile X tremor ataxia syndrome and Fragile X associated primary ovarian insufficiency, with the goal of finding new ways to help people affected by these disorders.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Baylor College of Medicine NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-10907682 on NIH RePORTER |
What this research studies
This research aims to explore the genetic and molecular mechanisms behind FMR1 premutation disorders, particularly focusing on Fragile X tremor ataxia syndrome (FXTAS) and Fragile X associated primary ovarian insufficiency (FXPOI). The project involves collaboration among leading research institutions to investigate the roles of CGG repeats in the FMR1 gene and how they contribute to these disorders. By integrating expertise from multiple centers, the research seeks to uncover potential therapeutic approaches that could improve patient outcomes. The Administrative Core will ensure effective management and coordination of the research activities.
Who could benefit from this research
Good fit: Ideal candidates for participation are individuals with FMR1 premutation disorders, including FXTAS and FXPOI.
Not a fit: Patients without FMR1 premutation disorders or those not affected by Fragile X-related conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for individuals affected by Fragile X disorders.
How similar studies have performed: Previous research has shown promise in understanding the genetic mechanisms of Fragile X disorders, suggesting that this approach could yield valuable insights.
Where this research is happening
Houston, United States
- Baylor College of Medicine — Houston, United States (Active)
Researchers
- Principal investigator: Nelson, David Loren — Baylor College of Medicine
- Study coordinator: Nelson, David Loren
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.